These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 19077040)

  • 41. Cytogenetic evaluation of isochromosome 17q in posterior fossa tumors of children and correlation with clinical outcome in medulloblastoma. Detection of a novel chromosomal abnormality.
    DeChiara C; Borghese A; Fiorillo A; Genesio R; Conti A; D'Amore R; Pettinato G; Varone A; Maggi G
    Childs Nerv Syst; 2002 Aug; 18(8):380-4. PubMed ID: 12192498
    [TBL] [Abstract][Full Text] [Related]  

  • 42. C-kit expression and mutational analysis in medulloblastoma.
    Chilton-Macneill S; Ho M; Hawkins C; Gassas A; Zielenska M; Baruchel S
    Pediatr Dev Pathol; 2004; 7(5):493-8. PubMed ID: 15547773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
    Thompson MC; Fuller C; Hogg TL; Dalton J; Finkelstein D; Lau CC; Chintagumpala M; Adesina A; Ashley DM; Kellie SJ; Taylor MD; Curran T; Gajjar A; Gilbertson RJ
    J Clin Oncol; 2006 Apr; 24(12):1924-31. PubMed ID: 16567768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis.
    Kim W; Choy W; Dye J; Nagasawa D; Safaee M; Fong B; Yang I
    J Clin Neurosci; 2011 Jul; 18(7):886-90. PubMed ID: 21640908
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model.
    Presutti D; Ceccarelli M; Micheli L; Papoff G; Santini S; Samperna S; Lalli C; Zentilin L; Ruberti G; Tirone F
    PLoS One; 2018; 13(3):e0194206. PubMed ID: 29538458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. All-trans-retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway.
    Gumireddy K; Sutton LN; Phillips PC; Reddy CD
    Clin Cancer Res; 2003 Sep; 9(11):4052-9. PubMed ID: 14519626
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
    Manoranjan B; Wang X; Hallett RM; Venugopal C; Mack SC; McFarlane N; Nolte SM; Scheinemann K; Gunnarsson T; Hassell JA; Taylor MD; Lee C; Triscott J; Foster CM; Dunham C; Hawkins C; Dunn SE; Singh SK
    Stem Cells; 2013 Jul; 31(7):1266-77. PubMed ID: 23592496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histologic features and prognosis in pediatric medulloblastoma.
    Verma S; Tavaré CJ; Gilles FH
    Pediatr Dev Pathol; 2008; 11(5):337-43. PubMed ID: 18201118
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.
    Bai AH; Milde T; Remke M; Rolli CG; Hielscher T; Cho YJ; Kool M; Northcott PA; Jugold M; Bazhin AV; Eichmüller SB; Kulozik AE; Pscherer A; Benner A; Taylor MD; Pomeroy SL; Kemkemer R; Witt O; Korshunov A; Lichter P; Pfister SM
    Acta Neuropathol; 2012 Apr; 123(4):529-38. PubMed ID: 22134538
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wnt activation as a therapeutic strategy in medulloblastoma.
    Manoranjan B; Venugopal C; Bakhshinyan D; Adile AA; Richards L; Kameda-Smith MM; Whitley O; Dvorkin-Gheva A; Subapanditha M; Savage N; Tatari N; McKenna D; Bassey-Archibong B; Winegarden N; Hallett R; Provias JP; Yarascavitch B; Ajani O; Fleming A; Bader GD; Pugh TJ; Doble BW; Singh SK
    Nat Commun; 2020 Aug; 11(1):4323. PubMed ID: 32859895
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and cancer of the cerebellum.
    Hatten ME; Roussel MF
    Trends Neurosci; 2011 Mar; 34(3):134-42. PubMed ID: 21315459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuronal differentiation associated with Gli3 expression predicts favorable outcome for patients with medulloblastoma.
    Miyahara H; Natsumeda M; Yoshimura J; Ogura R; Okazaki K; Toyoshima Y; Fujii Y; Takahashi H; Kakita A
    Neuropathology; 2014 Feb; 34(1):1-10. PubMed ID: 23889567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CTGF expression is indicative of better survival rates in patients with medulloblastoma.
    Cruzeiro GAV; Lira RCP; de Almeida Magalhães T; Scrideli CA; Valera ET; Baumgartner M; Tone LG
    Cancer Gene Ther; 2020 May; 27(5):378-382. PubMed ID: 31073205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma.
    Zhang Y; Wang T; Wang S; Xiong Y; Zhang R; Zhang X; Zhao J; Yang AG; Wang L; Jia L
    Cancer Res; 2018 Feb; 78(4):962-973. PubMed ID: 29229597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medulloblastoma with multi-lineage differentiation including myogenic and melanotic elements: a case report with molecular data.
    Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C
    Clin Neuropathol; 2014; 33(2):122-7. PubMed ID: 24131750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas.
    Kaur K; Kakkar A; Kumar A; Purkait S; Mallick S; Suri V; Sharma MC; Julka PK; Gupta D; Suri A; Sarkar C
    J Neurooncol; 2016 Dec; 130(3):423-430. PubMed ID: 27576698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Macrophages in SHH subgroup medulloblastoma display dynamic heterogeneity that varies with treatment modality.
    Dang MT; Gonzalez MV; Gaonkar KS; Rathi KS; Young P; Arif S; Zhai L; Alam Z; Devalaraja S; To TKJ; Folkert IW; Raman P; Rokita JL; Martinez D; Taroni JN; Shapiro JA; Greene CS; Savonen C; Mafra F; Hakonarson H; Curran T; Haldar M
    Cell Rep; 2021 Mar; 34(13):108917. PubMed ID: 33789113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinicopathological features of medulloblastoma: an overview with an emphasis on molecular biology.
    de Haas TG; Kool M
    Clin Neuropathol; 2007; 26(3):93-110. PubMed ID: 19157001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A simplified approach using Taqman low-density array for medulloblastoma subgrouping.
    Cruzeiro GAV; Salomão KB; de Biagi CAO; Baumgartner M; Sturm D; Lira RCP; de Almeida Magalhães T; Baroni Milan M; da Silva Silveira V; Saggioro FP; de Oliveira RS; Dos Santos Klinger PH; Seidinger AL; Yunes JA; de Paula Queiroz RG; Oba-Shinjo SM; Scrideli CA; Nagahashi SMK; Tone LG; Valera ET
    Acta Neuropathol Commun; 2019 Mar; 7(1):33. PubMed ID: 30832734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pediatric medulloblastoma in the molecular era: what are the surgical implications?
    Kameda-Smith MM
    Cancer Metastasis Rev; 2020 Mar; 39(1):235-243. PubMed ID: 32095940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.